See my Jan 11 post.
On Novemeber 11,2008, Johnson and Johnson bought OMRIX for $438 M in cash when they got their FDA fibrin patch approval
in May 2008.
IPO fund raising for 2008 has gotten cut in half and withdrawn
in this bad financial market.
According to my research ,CTGI is missing a big market in Japan where there is a highly emotive feeling against
blood transfusions during surgery.
A joint venture with a Japanese company would do wonders for
the price of our stock.
Only thing is I do not know whether LTC has patents
filed and approved for Japan and whether FDA or EU aaprovals
would cover Japan or whether it would require some other filing.
Does anybody know if we have filed Japanese patents
or FDa filings there?
Regards,
bbhuey
P.S. There is an old farm saying in winter when you
see barren land you don't know what can be planted
unless you have the patience to wait for the harvest.